Liquid biopsy techniques using cell-free DNA (cfDNA) play an increasingly important role in the characterization and surveillance of solid tumors. For blood cancers, molecular response assessment ...
Traditional biomarkers used in kidney transplant care lack sensitivity and specificity for early detection Donor-derived cell-free DNA is used as a biomarker for detecting early graft rejection or ...
Since the discovery of cell-free DNA (cfDNA) in 1948, shedded DNA fragments have been applied to technologies ranging from pre-natal genetic screening and ...